Regarding long-term statin therapy: are we trading stronger hearts for weaker brains?

Area of Science:

• Neuroscience
• Cardiovascular Medicine
• Pharmacology

Background:

• Long-term statin therapy is widely prescribed for cardiovascular disease prevention.
• Concerns exist regarding potential adverse effects of statins on brain structure and function.
• Emerging data suggest statins might exacerbate cerebral small vessel disease and impair myelination.

Purpose of the Study:

• To critically evaluate the impact of long-term statin therapy on brain health.
• To investigate potential mechanisms, including cholesterol depletion and effects on oligodendrocyte function.
• To identify the need for independent, prospective trials to clarify clinical ramifications.

Main Methods:

• Analysis of randomized prospective trials is proposed.
• Trials must specifically investigate statin effects on brain structure and function.
• Exclusion of industry-funded studies and investigators with financial ties to the pharmaceutical industry is crucial.

Main Results:

• Data suggest potential negative impacts on myelination and cerebral small vessel disease.
• Mechanisms may involve cholesterol depletion and altered amyloid-β metabolism.
• Clinical consequences could negatively affect quality of life.

Conclusions:

• The potential risks of long-term statin therapy on brain health warrant further investigation.
• Independent research is essential to validate findings and inform clinical guidelines.
• Clarifying these effects is critical given the expanding use of statins globally.